Atlas Trials

Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab

Clinical trial NCT04175834 · COMPLETED

Trial details

NCT number
NCT04175834
Sponsor
Providence Health & Services
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple SclerosisInfusion Reaction
Start date
2020-02-05
Primary completion
2022-05-13
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.